Moderna Inc MRNA
News
Moderna Outlines Next Phase of Growth at Analyst Day
Moderna Announces JAMA Network Open Publication of Real-World Comparative Effectiveness Data for mNEXSPIKE (COVID-19 Vaccine, mRNA) in Adults Aged 65 Years and Older
Moderna to Present at Upcoming Conference in November 2026
Moderna raises its revenue outlook - but all eyes are on what happens next with its cancer vaccine
Moderna Swings to 3Q Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes — Update
Moderna Lifts Outlook, Swings to 3Q Profit
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates
Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study
Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting
The excitement around Moderna's cancer vaccine is cooling. Here's why.
Moderna's cancer vaccine is 'likely' to get approved. Skeptics question if it will be the best option.
Lost Money on Moderna, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 23.07% Share Price Drop
Did You Lose Money on Moderna, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 23.07% Share Price Decline
The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?
Moderna Named a Top Employer by Science for Twelfth Consecutive Year
Moderna's cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
Lost Money on Moderna, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 23.07% Stock Decline

